New hope for controlling rare blood disorder that attacks kidneys
NCT ID NCT07308574
Summary
This study is testing how well the drug ravulizumab works to control atypical hemolytic uremic syndrome (aHUS), a rare disease where the immune system attacks blood cells and damages kidneys. The research will follow 20 participants for 26 weeks to see if the treatment improves their blood platelet counts and kidney function. This is a post-marketing study, meaning the drug is already approved but researchers want to learn more about its real-world effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATYPICAL HEMOLYTIC-UREMIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
NOT_YET_RECRUITINGBunkyō City, 113-8655, Japan
-
Research Site
NOT_YET_RECRUITINGHirakata-shi, 573-1191, Japan
-
Research Site
NOT_YET_RECRUITINGIruma-Gun, 350-0495, Japan
-
Research Site
NOT_YET_RECRUITINGKyoto, 602-8566, Japan
-
Research Site
NOT_YET_RECRUITINGMatsumoto-shi, 390-8621, Japan
-
Research Site
NOT_YET_RECRUITINGMiyazaki, 889-1692, Japan
-
Research Site
RECRUITINGNagoya, 466-8650, Japan
-
Research Site
NOT_YET_RECRUITINGNara, 630-8581, Japan
-
Research Site
NOT_YET_RECRUITINGNerima-ku, 177-8521, Japan
-
Research Site
NOT_YET_RECRUITINGSapporo, 060-8638, Japan
-
Research Site
NOT_YET_RECRUITINGShinjuku-ku, 162-8666, Japan
-
Research Site
NOT_YET_RECRUITINGTsu, 514-8507, Japan
Conditions
Explore the condition pages connected to this study.